We are live on
!
Find out more
AAP
Ardsley Advisory Partners Portfolio holdings
AUM
$960M
1-Year Est. Return
207.76%
This Fund
S&P 500
This Quarter
Est. Return
+10.08%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$644M
AUM Growth
+$39.6M
(+6.6%)
Cap. Flow
+$5.56M
Cap. Flow
% of AUM
0.86%
Top 10 Holdings %
Top 10 Hldgs %
35.41%
Holding
200
New
77
Increased
40
Reduced
23
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$14.2M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$12.7M |
| 3 |
CELG
Celgene Corp
CELG
|
+$12.4M |
| 4 |
PEGI
Pattern Energy Group Inc. Class A
PEGI
|
+$8.27M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$7.96M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NRF
NorthStar Realty Finance Corp.
NRF
|
+$15M |
| 2 |
AKRX
Akorn Inc
AKRX
|
+$12.7M |
| 3 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
+$9.32M |
| 4 |
GLBL
TerraForm Global, Inc. Class A Common Stock
GLBL
|
+$7.95M |
| 5 |
MRT
MedEquities Realty Trust, Inc.
MRT
|
+$7.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.08% |
| 2 | Technology | 10.1% |
| 3 | Financials | 8.58% |
| 4 | Energy | 7.12% |
| 5 | Real Estate | 6.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
CALL
Freeport-McMoran
FCX
$91.2B
| $1.34M | 0.21% |
+100,000
| New | +$1.44M |
|
|
JKS
77
CALL
JinkoSolar
JKS
$777M
| $1.24M | 0.19% |
+75,000
| New | +$1.19M |
|
78
iShares Biotechnology ETF
IBB
$9.52B
| $1.17M | 0.18% |
12,000
| – | – |
|
|
POT
79
DELISTED
Potash Corp Of Saskatchewan
POT
| $999K | 0.16% |
+58,500
| New | +$1.06M |
|
80
Invesco DB Agriculture Fund
DBA
$1.23B
| $989K | 0.15% |
+50,000
| New | +$1.02M |
|
|
AIOT
81
PowerFleet Inc
AIOT
$525M
| $894K | 0.14% |
+141,242
| New | +$858K |
|
82
RingCentral
RNG
$4.48B
| $849K | 0.13% |
+30,000
| New | +$742K |
|
83
PUT
Bunge Global
BG
$20.4B
| $793K | 0.12% |
+10,000
| New | +$749K |
|
84
Vertex Pharmaceuticals
VRTX
$122B
| $765K | 0.12% |
+7,000
| New | +$616K |
|
85
AXT Inc
AXTI
$3.07B
| $725K | 0.11% |
125,000
+105,000
| +525% | +$652K |
|
86
Broadcom
AVGO
$1.85T
| $657K | 0.1% |
+30,000
| New | +$618K |
|
87
UnitedHealth
UNH
$383B
| $656K | 0.1% |
4,000
-500
| -11% | -$81.9K |
|
|
AET
88
DELISTED
Aetna Inc
AET
| $638K | 0.1% |
+5,000
| New | +$628K |
|
89
Eli Lilly
LLY
$1.03T
| $631K | 0.1% |
7,500
+1,000
| +15% | +$80.1K |
|
90
NetApp
NTAP
$34.1B
| $628K | 0.1% |
+15,000
| New | +$591K |
|
91
Take-Two Interactive
TTWO
$46.3B
| $593K | 0.09% |
10,000
-7,000
| -41% | -$391K |
|
92
Pfizer
PFE
$142B
| $582K | 0.09% |
17,918
+5,270
| +42% | +$166K |
|
93
Western Digital
WDC
$184B
| $578K | 0.09% |
9,261
-123,701
| -93% | -$7.11M |
|
94
Zimmer Biomet
ZBH
$18.4B
| $549K | 0.09% |
4,635
+1,030
| +29% | +$117K |
|
|
FOE
95
DELISTED
Ferro Corporation
FOE
| $532K | 0.08% |
+35,000
| New | +$502K |
|
|
ZAYO
96
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $526K | 0.08% |
+16,000
| New | +$510K |
|
97
Applied Materials
AMAT
$398B
| $525K | 0.08% |
+13,500
| New | +$485K |
|
|
COUP
98
DELISTED
Coupa Software Incorporated
COUP
| $508K | 0.08% |
+20,000
| New | +$511K |
|
|
HDSN
99
Hudson Technologies
HDSN
$244M
| $495K | 0.08% |
75,000
-50,000
| -40% | -$364K |
|
100
CALL
Under Armour
UAA
$2.91B
| $495K | 0.08% |
+25,000
| New | +$583K |
|
Similar funds
NA
MK
QIM
JVBC
TFP
UWPG
LOAMU
FWM
Ardsley Advisory Partners's Q1 2017 Portfolio in Review
As of Q1 2017, Ardsley Advisory Partners held 200 positions worth $644M, up 6.6% from $604M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Ardsley Advisory Partners's Q1 2017 filing shows 77 new, 40 increased, 23 reduced and 50 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 89,500 shares worth $7.86M. The largest sale was NorthStar Realty Finance Corp., an estimated $15M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 7.3% a quarter earlier, followed by Technology and Financials.
- Ardsley Advisory Partners's largest Q1 2017 buy was BioMarin Pharmaceuticals: 89,500 shares worth $7.86M.
- Ardsley Advisory Partners added most to State Street SPDR S&P Biotech ETF in Q1 2017, an estimated $14.2M increase.
- Ardsley Advisory Partners's biggest Q1 2017 reduction was Akorn Inc, cutting an estimated $12.7M.
- Ardsley Advisory Partners fully exited NorthStar Realty Finance Corp. in Q1 2017, selling an estimated $15M.
- Ardsley Advisory Partners's ten largest holdings make up 35% of its $644M portfolio in Q1 2017.
- Ardsley Advisory Partners opened 77 new positions and closed 50 in Q1 2017.
- Ardsley Advisory Partners's portfolio value rose 6.6% quarter-over-quarter to $644M.
Based on Ardsley Advisory Partners's 13F filing for Q1 2017, filed 15 May 2017.